2021 Report Leber Congenital Amaurosis Drugs In Development – Featuring Atsena Therapeutics, Editas Medicine and Generation Bio Among Others – ResearchAndMarkets.com
DUBLIN--(BUSINESS WIRE)--The "Leber Congenital Amaurosis (LCA) (Ophthalmology) - Drugs In Development, 2021" report has been added to ResearchAndMarkets.com's offering. This report provides an overview of the Leber Congenital Amaurosis (Genetic Disorders) pipeline landscape. Leber congenital amaurosis is an eye disorder that primarily affects the retina, which is the specialized tissue at the back of the eye that detects light and color. This condition is the most common cause of inherited blin